Article Details

Imvax Presents Preclinical Data at SITC 2022 Supporting Mechanism of Action and Anti ...

Retrieved on: 2022-11-11 05:05:01

Tags for this article:

Click the tags to see associated articles and topics

Imvax Presents Preclinical Data at SITC 2022 Supporting Mechanism of Action and Anti .... View article details on hiswai:

Excerpt

Imvax is a clinical-stage biotechnology company with a unique platform ... immune system against the entire antigen signature of their tumor.

Article found on: www.pharmiweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up